ARIA News 5.76 08/01/2014 04:36:15 Ariad Pharmaceuticals (AR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ariad Pharmaceuticals (ARIA) 5.76 $ARIA

3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:44AM CDT
These stocks are well positioned in today’s market environment.

3 Biotech Stocks Under $10 in Breakout Territory
at The Street - Wed Jul 30, 5:00AM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.

Storm The Castle: ARIAD Pharmaceuticals (ARIA)
at The Street - Tue Jul 29, 1:35PM CDT
Trade-Ideas LLC identified ARIAD Pharmaceuticals (ARIA) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Most active Nasdaq-traded stocks
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

3 Huge Stocks to Trade (or Not)
at The Street - Thu Jul 24, 2:09PM CDT
Here's how to trade some of the most active stocks on the market today.

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Gains 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:25AM CDT
Ariad Pharmaceuticals (ARIA) was a big mover last session, with shares rising over 15% on the day.

'Fast Money' Recap: Facebook and Analysts' Expectations
at The Street - Thu Jul 24, 4:00AM CDT
The trading panel discussed why they like Facebook's earnings and why they'd avoid Cheesecake Factory.

Ariad Pharmaceuticals Rises 15.29% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Jul 23, 4:36PM CDT
Ariad Pharmaceuticals (NASDAQ:ARIA) traded in a range yesterday that spanned from a low of $5.12 to a high of $5.94. Yesterday, the shares gained 15.3%, which took the trading range above the 3-day high of $5.31 on volume of 24.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Ariad Pharmaceuticals Down 13.1% Since SmarTrend Downtrend Call (ARIA)
Comtex SmarTrend(R) - Wed Jul 23, 9:19AM CDT
SmarTrend identified a Downtrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on July 8th, 2014 at $6.07. In approximately 2 weeks, Ariad Pharmaceuticals has returned 13.11% as of today's recent price of $5.27.

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market
at The Street - Wed Jul 16, 10:40AM CDT
Recent comments by Fed Chair Janet Yellen and activist investor Carl Icahn have led to selling pressure in small-cap stocks.

ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results
Business Wire - Wed Jul 16, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the market opens. Following the announcement, at 8:30 a.m. Eastern Time, company management will host a conference call and webcast discussion of the results and provide a general corporate update.

Ariad Stock's Biggest Risk Is Its Only Hope
Brian Wilson, The Motley Fool - Motley Fool - Tue Jul 15, 4:00PM CDT
Overreliance on its blood cancer drug Iclusig (ponatinib) continues to make Ariad Pharmaceuticals an incredibly risky biotech play, despite the mature company's relatively low market cap of $1.1 billion. After a dramatic FDA recall in 2013 based...

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.

ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe
Business Wire - Mon Jul 14, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has provided the Company with a request for limited additional information regarding Iclusig(R) (ponatinib) as part of its ongoing review under the Article 20 referral procedure. The PRAC has requested further information regarding proposed dose modifications after achievement of a response and patient monitoring and details concerning a risk management plan. Following ARIAD's response and input from the agency's Scientific Advisory Group, the Company expects that the PRAC will complete its review and make final recommendations to the Committee for Medicinal Products for Human Use (CHMP) at its meeting in October 2014.

ARIAD Pharmaceuticals (ARIA) Is Water-Logged And Getting Wetter Today
at The Street - Tue Jul 08, 9:39AM CDT
Trade-Ideas LLC identified ARIAD Pharmaceuticals (ARIA) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:10PM CDT
UCB SA (UCBJF) and Dermira have entered into a licensing agreement for the development and commercialization of Cimzia in dermatology.

OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 3:30PM CDT
OncoGenex Pharmaceuticals, Inc. (OGXI) announced that apatorsen is in phase II study (Cedar) for advanced squamous cell lung cancer.

Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 7:42AM CDT
Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock
Scroll down for more posts ▼

Top 10 Most Recent News Articles

APEC's Shared-Prosperity Message Needs More Detail

Updated Category News Views 13

Geese make handsome symbols, but markets cannot underwrite a metaphor. The Nov. 18, 2026 report from Xinhua News Agency looks back to remarks Chinese President Xi Jinping made 12 years ago, when he used swan geese to urge APEC economies toward greater cooperation and a new collective flight. Its present-day message is plainly hopeful: the APEC family is moving across the...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 119

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 85

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 130

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence

Updated Category News Views 53

Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 28

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 19

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Gozney Brings in Armin Boehm for a Global Growth Push

Updated Category News Views 35

A pizza oven company has just made a very grown-up management move. Gozney appointed Armin Boehm as Global President, effective from October 31, putting an experienced consumer-brand operator beside founder, designer and CEO Tom Gozney at a moment when the business says it is becoming a global omnichannel operation. This is not the sort of announcement that comes with...

Continue Reading
Makers Nutrition Credit Puts a Clock on New Brands

Updated Category News Views 196

A few cents per bottle can look downright beautiful when a new supplement brand is staring at its first production bill. Makers Nutrition announced on November 17 a Black Friday manufacturing-credit offer aimed at entrepreneurs and established sellers launching a new formulation, with qualifying new orders eligible for as much as $0.45 per unit through November 29, 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Securities Fraud Investigation Casts Shadow on Driven Brands

Updated Category News Views 331

The Unfolding Drama Surrounding Driven Brands Out of nowhere, the waters are getting choppy for Driven Brands Holdings, and it’s not just a casual dip; more like a tsunami warning. Ademi LLP is cranking up the heat with an investigation into possible securities fraud that’s got investors scratching their heads and probably running for cover. What’s the Big Deal?...

Continue Reading
Info-Tech Research Group Expands Focus in Asia-Pacific Markets

Updated Category News Views 292

Info-Tech Research Group Expands Its Global Footprint Info-Tech Research Group has recently expanded its global presence by launching a new office in Singapore while significantly ramping up investments in New Zealand. This strategic move enables the firm to provide more localized, outcome-driven support to IT leaders throughout Southeast Asia and the Australia-New...

Continue Reading
Laramide Resources' Strategic Exploration Plans in Kazakhstan

Updated Category News Views 144

Exploration Drilling Plans by Laramide Resources Laramide Resources Ltd., a leading organization in uranium exploration, has identified multiple promising targets within its Chu-Sarysu Project. This initiative is set to take place in a mineral-rich area renowned for its potential to yield significant deposits of uranium and other valuable minerals like rare earth elements...

Continue Reading
Stravito Unveils AI Personas for Accelerated Market Insights

Updated Category News Views 311

Stravito Introduces AI Personas for Enhanced Market Positioning Stravito supports brands in rapidly validating their ideas using advanced AI technology. In a dynamic market environment, Stravito has launched an initiative designed to drastically improve the speed and reliability of idea testing for brands. This revolutionary tool, known as Stravito AI Personas, transforms...

Continue Reading
Duni Introduces Innovative Take-Away Series Boosting Sustainability

Updated Category News Views 245

Duni Introduces Innovative Take-Away Series Boosting Sustainability Duni is excited to unveil a fresh series of take-away packaging that represents a significant leap towards sustainability. The company has developed new packaging solutions that feature a grey plastic base, which can significantly enhance recycling efforts compared to traditional black plastic. This move...

Continue Reading